α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 43, Issue 5, 2014, Pages 335-343

  Ding, Lei ^a   Zhang, Ziwen ^a   Shang, Duo ^a   Cheng, Jie ^a   Yuan, Hua ^a   Wu, Yunong ^a   Song, Xiaoling ^a   Jiang, Hongbing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial mesenchymal transition; Lymphogenesis; Myofibroblasts; Oral tongue squamous cell carcinoma; Prognosis

Indexed keywords

ACTA2 PROTEIN, HUMAN; ACTIN; CADHERIN; CDH2 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; LYVE1 PROTEIN, HUMAN; VESICULAR TRANSPORT PROTEIN; VIMENTIN;

ADULT; AGED; CANCER STAGING; CHEMISTRY; DISEASE COURSE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; MALE; MIDDLE AGED; MYOFIBROBLAST; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SECONDARY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TONGUE TUMOR; TUMOR MICROENVIRONMENT;

ACTINS; ADULT; AGED; ANTIGENS, CD; CADHERINS; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; MYOFIBROBLASTS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TONGUE NEOPLASMS; TUMOR MICROENVIRONMENT; VESICULAR TRANSPORT PROTEINS; VIMENTIN;

EID: 84898828756     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12143     Document Type: Article

References (42)

1. Annertz K, Anderson H, Palmer K, et al. The increase in incidence of cancer of the tongue in the Nordic countries continues into the twenty-first century. Acta Otolaryngol 2012; 132: 552-7.
2. Alho OP, Kantola S, Pirkola U, et al. Cancer of the mobile tongue in Finland-increasing incidence, but improved survival. Acta Oncol 1999; 38: 1021-4.
3. Moore SR, Johnson NW, Pierce AM, et al. The epidemiology of tongue cancer: a review of global incidence. Oral Dis 2000; 6: 75-84.
4. Li R, Koch WM, Fakhry C, et al. Distinct epidemiologic characteristics of oral tongue cancer patients. Otolaryngol Head Neck Surg 2013; 148: 792-6.
5. Wang J, Luo H, Liu F, et al. Quality of life in oral cancer patients-effects of tongue resection and sociocultural aspects. J Craniofac Surg 2013; 24: e493-6.
6. Camisasca DR, Silami MANC, Honorato J, et al. Oral squamous cell carcinoma: clinicopathological features in patients with and without recurrence. ORL J Otorhinolaryngol Relat Spec 2011; 73: 170-6.
7. Bello IO, Soini Y, Salo T. Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I). Oral Oncol 2010; 46: 630-5.
8. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11: 9-22.
9. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9: 239-52.
10. Bello IO, Vered M, Dayan D, et al. Cancer-associated fibroblasts, a parameter of the tumor microenvironment, overcomes carcinoma-associated parameters in the prognosis of patients with mobile tongue cancer. Oral Oncol 2011; 47: 33-8.
11. Vered M, Dayan D, Yahalom R, et al. Cancer-associated fibroblasts and epithelial-mesenchymal transition in metastatic oral tongue squamous cell carcinoma. Int J Cancer 2010; 127: 1356-62.
12. Orimo A, Weinberg RA. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 2006; 5: 1597-601.
13. Vered M, Allon I, Buchner A, et al. Stromal myofibroblasts and malignant transformation in a 4NQO rat tongue carcinogenesis model. Oral Oncol 2007; 43: 999-1006.
14. Vered M, Allon I, Buchner A, et al. Stromal myofibroblasts accompany modifications in the epithelial phenotype of tongue dysplastic and malignant lesions. Cancer Microenviron 2009; 2: 49-57.
15. Cirri P, Chiarugi P. Cancer associated fibroblasts: the dark side of the coin. Am J Cancer Res 2011; 1: 482-97.
16. Thode C, Jorgensen TG, Dabelsteen E, et al. Significance of myofibroblasts in oral squamous cell carcinoma. J Oral Pathol Med 2011; 40: 201-7.
17. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006; 127: 679-95.
18. Nguyen PT, Kudo Y, Yoshida M, et al. N-cadherin expression is correlated with metastasis of spindle cell carcinoma of head and neck region. J Oral Pathol Med 2011; 40: 77-82.
19. Dudas J, Bitsche M, Schartinger V, et al. Fibroblasts produce brain-derived neurotrophic factor and induce mesenchymal transition of oral tumor cells. Oral Oncol 2011; 47: 98-103.
20. Gao MQ, Kim BG, Kang S, et al. Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro. J Cell Sci 2010; 123: 3507-14.
21. Giannoni E, Bianchini F, Masieri L, et al. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res 2010; 70: 6945-56.
22. Liu LK, Jiang XY, Zhou XX, et al. Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome. Mod Pathol 2010; 23: 213-24.
23. Frech S, Hormann K, Riedel F, et al. Lymphatic vessel density in correlation to lymph node metastasis in head and neck squamous cell carcinoma. Anticancer Res 2009; 29: 1675-9.
24. Josson S, Matsuoka Y, Chung LW, et al. Tumor-stroma co-evolution in prostate cancer progression and metastasis. Semin Cell Dev Biol 2010; 21: 26-32.
25. Fujii N, Shomori K, Shiomi T, et al. Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance. J Oral Pathol Med 2012; 41: 444-51.
26. Shimoda M, Mellody KT, Orimo A. Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Semin Cell Dev Biol 2010; 21: 19-25.
27. Zhang Y, Tang H, Cai J, et al. Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion. Cancer Lett 2011; 303: 47-55.
28. Zhi K, Shen X, Zhang H, et al. Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers. J Exp Clin Cancer Res 2010; 29: 66.
29. Albert S, Hourseau M, Halimi C, et al. Prognostic value of the chemokine receptor CXCR4 and epithelial-to-mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue. Oral Oncol 2012; 48: 1263-71.
30. Zheng G, Lyons JG, Tan TK, et al. Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells. Am J Pathol 2009; 175: 580-91.
31. Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009; 119: 1429-37.
32. Diamond ME, Sun L, Ottaviano AJ, et al. Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium. J Cell Sci 2008; 121: 2197-207.
33. Hazan RB, Qiao R, Keren R, et al. Cadherin switch in tumor progression. Ann N Y Acad Sci 2004; 1014: 155-63.
34. Pyo SW, Hashimoto M, Kim YS, et al. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome. J Craniomaxillofac Surg 2007; 35: 1-9.
35. Hazan RB, Phillips GR, Qiao RF, et al. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000; 148: 779-90.
36. Nakajima S, Doi R, Toyoda E, et al. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res 2004; 10: 4125-33.
37. Erez N, Truitt M, Olson P, et al. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 2010; 17: 135-47.
38. Zhang Z, Helman JI, Li LJ. Lymphangiogenesis, lymphatic endothelial cells and lymphatic metastasis in head and neck cancer-a review of mechanisms. Int J Oral Sci 2010; 2: 5-14.
39. Baydar DE, Baseskioglu B, Ozen H, et al. Prognostic significance of lymphovascular invasion in clinically localized prostate cancer after radical prostatectomy. ScientificWorldJournal 2008; 8: 303-12.
40. Kikuchi E, Margulis V, Karakiewicz PI, et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 2009; 27: 612-18.
41. Song YJ, Shin SH, Cho JS, et al. The Role of lymphovascular invasion as a prognostic factor in patients with lymph node-positive operable invasive breast cancer. J Breast Cancer 2011; 14: 198-203.
42. Jackson DG, Prevo R, Clasper S, et al. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 2001; 22: 317-21.